ADTX · Aditxt, Inc.
$0.00
-0.01 (-80.00%)
At close · Jun 25
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of these factors, we believe that this creates substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$4.99M
Shares
815,921
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3195
-97.6%
FY2025
Net Income
-$43.1M
-6.8%
FY2025
Gross Margin
8.39%
+376.7pp
FY2025
Operating Margin
-612542.22%
-591746.1pp
FY2025
Diluted EPS
-$31,153.41
+100%
FY2025
Operating Cash Flow
-$25.69M
-53.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $14.34K | $3195 | $133.99K | $645.18K | $933.72K | $105.03K | — | — | |
| $11.48K | $2927 | $627.47K | $756.84K | $766.78K | $77.98K | — | — | |
| — | — | — | — | — | — | $154.26K | $30.36K | |
| $2852 | $268 | -$493.49K | -$111.66K | $166.94K | $27.06K | — | — | |
| — | 8.39% | -368.32% | -17.31% | 17.88% | 25.76% | — | — | |
| $3.03M | $3.19M | $10.89M | $7.07M | $7.27M | $5.04M | $937.97K | $175.44K | |
| — | $402K | $197.86K | $269.28K | $1.85M | — | — | — | |
| $14.94M | $15.97M | $16.29M | $18.61M | $15.99M | $22.08M | $7.85M | $5.69M | |
| — | — | — | — | $1.85M | $334.98K | $81.99K | $551 | |
| $3334 | $3333 | $3333 | $107.56K | $107K | $107K | — | — | |
| $18.33M | $19.57M | $27.37M | $25.95M | $25.65M | $41.96M | $8.87M | $5.87M | |
| -$18.32M | -$19.57M | -$27.86M | -$26.06M | -$25.48M | -$41.93M | -$8.87M | -$5.87M | |
| — | -612542.22% | -20796.13% | -4039.58% | -2728.89% | -39925.1% | — | — | |
| $550.79K | $681.16K | $4.19M | $4.2M | — | $15.79K | $5842 | — | |
| $200.17K | $200.18K | $1454 | $10.17K | $57.35K | $3101 | $563 | — | |
| -$34.7M | -$23.22M | -$7.16M | -$6.33M | -$2.17M | -$4.44M | -$277.02K | $43.07K | |
| -$53.02M | -$42.79M | -$35.02M | -$32.39M | -$27.65M | -$46.37M | -$9.15M | — | |
| -$53.2M | -$43.1M | -$40.35M | -$32.7M | -$27.65M | -$46.37M | -$9.15M | -$5.83M | |
| — | -1349028.2% | -30117.92% | -5068.49% | -2961.28% | -44148.91% | — | — | |
| -$1.07M | -$1.07M | -$573.57K | -$9608 | — | — | — | — | |
| — | — | — | -$32.7M | -$27.69M | -$46.27M | — | — | |
| — | -$41.53M | -$35.02M | — | — | — | — | — | |
| USD/shares | $166,129.08 | -$31,153.41 | -$597,980,210.94 | -$659,949,850.08 | -$145,745,049,600.00 | -$1,183,104,576,000.00 | — | — |
| USD/shares | $166,129.08 | -$31,153.41 | -$597,980,210.94 | -$659,949,850.08 | -$145,374,048,000.00 | -$1,183,104,576,000.00 | — | — |
| shares | — | 1383.5185 | 0.0741 | 0.0495 | 0.0002 | 0 | 0 | 0 |
| shares | — | 1383.5185 | 0.0741 | 0.0495 | 0.0002 | 0 | 0 | 0 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 172 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.57×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 149 similar-size Biotechnology companies (of 515 listed).